CSNK1A1 and posterior cortical atrophy: Assessing CSNK1A1 expression in the Tomlins et al. 2007 dataset [49] revealed that CSNK1A1 was significantly upregulated in cancer samples compared to PCa precursor samples (adjusted p-value of 3.793 × 10−4 logFC 0.401), although this dataset is quite small.